White matter protection with insulin-like growth factor-1 after hypoxia-ischaemia in preterm foetal sheep

Guido Wassink1, Kenta H T Cho1, Sam Mathai1

  • 1Department of Physiology, University of Auckland, Private Bag 92019, Auckland 1023, New Zealand.

Brain Communications
|November 7, 2024
PubMed

Insights

Delayed insulin-like growth factor-1 treatment improved white matter maturation in preterm sheep after hypoxia-ischaemia. This intervention reduced brain injury and inflammation, offering potential for treating neurodevelopmental impairment in extremely preterm infants.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Neonatal Medicine

Background:

  • Perinatal hypoxia-ischaemia causes neurodevelopmental impairment in preterm infants.
  • Current treatments for this condition are limited.
  • Insulin-like growth factor-1 (IGF-1) shows promise in reducing acute brain injury, but its chronic effects on white matter are unknown.

Purpose of the Study:

  • To investigate the efficacy of prolonged, delayed insulin-like growth factor-1 treatment on chronic white matter injury following perinatal hypoxia-ischaemia in preterm sheep.
  • To assess the impact of IGF-1 on oligodendrocyte development, inflammation, and functional recovery.

Main Methods:

  • Preterm-equivalent fetal sheep underwent asphyxia (umbilical cord occlusion) or sham procedures.
  • Animals recovered for 3 or 35 days.
  • The 35-day recovery groups received intracerebroventricular infusions of IGF-1 or vehicle.
  • White matter injury, oligodendrocyte markers, inflammation, and EEG activity were analyzed.

Main Results:

  • Asphyxia led to ventricular enlargement, white matter loss, reduced myelin basic protein, and decreased oligodendrocyte numbers.
  • Persistent inflammation and caspase-3 activation were observed post-asphyxia.
  • IGF-1 treatment improved frontal white matter area, increased oligodendrocyte numbers, and reduced astrogliosis and microgliosis.
  • IGF-1 treated fetuses showed faster recovery of EEG power.

Conclusions:

  • Delayed, prolonged IGF-1 treatment can improve functional maturation of periventricular white matter after severe asphyxia in the immature brain.
  • IGF-1 exerts its effects partly by suppressing chronic neuroinflammation.
  • These findings suggest a potential therapeutic strategy for neurodevelopmental impairment in extremely preterm infants.

Related Concept Videos